Structure-based design of novel calcineurin (PP2B) inhibitors

https://doi.org/10.1016/S0960-894X(97)00141-8Get rights and content

Abstract

The design, synthesis, and evaluation of small molecule, in vitro, inhibitors of human calcineurin is described. These ligands were derived from the known nonspecific phosphatase inhibitor endothall, and were modified to enhance binding and selectivity toward calcineurin using protein crystal structure information.

The design, synthesis and evaluation of small molecule inhibitors of human calcineurin is described. These ligands were derived from the known nonspecific phosphatase inhibitor endothall, and were modified to enhance binding and selectivity toward calcineurin using protein crystal structure information.

  1. Download : Download full-size image

References (53)

  • P.G. McCaffrey et al.

    J. Biol. Chem.

    (1993)
  • S.L. Schreiber et al.

    Tetrahedron

    (1992)
  • J. Liu et al.

    Cell

    (1991)
  • J.P. Griffith et al.

    Cell

    (1995)
  • R.E. Honkanan et al.

    Toxicon

    (1994)
  • Y.-M. Li et al.

    Biochem. Pharmacol.

    (1993)
  • R.E. Honkanen

    FEBS Lett.

    (1993)
  • R. Eldridge et al.

    Toxicol. appl. Pharmacol.

    (1995)
  • Y. Hashimoto et al.

    J. Biol. Chem.

    (1990)
  • M.N. Rivetna et al.

    Bioorg. Med. Chem. Lett.

    (1995)
  • M.-P. Egloff et al.

    J. Mol. Biol.

    (1995)
  • R.E. Babine et al.

    Bioorg. Med. Chem. Lett.

    (1996)
  • J.W. Williams et al.

    Methods in Enzymology

    (1979)
  • D.K. Gehlhaar et al.

    Chemistry & Biology

    (1995)
  • C.B. Klee et al.

    Advances in Enzymology and Related Areas of Molecular Biology

    (1988)
  • C. Pallen et al.
  • M.J. Hubbard et al.

    Biochemistry

    (1989)
  • D. Guerini et al.

    Adv. Protein Phosphatases

    (1991)
  • N.A. Clipstone et al.

    Nature

    (1992)
  • M.J. Tocci et al.

    J. Immunol.

    (1989)
  • F.J. Dumont et al.

    J. Immunol.

    (1990)
  • C. Randak et al.

    EMBO J.

    (1990)
  • W.M. Flanagan et al.

    Nature

    (1991)
  • S.J. O'Keefe et al.

    Nature

    (1991)
  • J. Jain et al.

    Nature

    (1993)
  • S.L. Schreiber

    Science

    (1991)
  • Cited by (38)

    • Synthesis of cytotoxic spirocyclic imides from a biomass-derived oxanorbornene

      2021, Tetrahedron
      Citation Excerpt :

      Its synthesis is readily achieved through the Diels-Alder [4 + 2] cycloaddition between furan and maleic anhydride, followed by subsequent reduction of the alkene [18]. This has led to numerous investigations into synthetic analogues of cantharidin 5, with several groups reporting structure-activity relationships (SAR) for cytotoxicity and PP1/PP2A inhibition following modification of the 7-oxabicylo[2.2.1]heptyl ring system [19–23] or ring-opening the anhydride [24–29]. However, these synthetic analogues have seldom shown cytotoxicity comparable to cantharidin 5, suggesting only limited modification of the parent compound is tolerated.

    • Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity

      2011, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      Norcantharidin is reported to induce apoptosis in human cervical,13,14 oral,15,16 melanoma,17 ginival,15 bladder,18 adenocystic carcinoma,19 glioblastoma,20 bone,21 leukaemia,21 ovarian,22 liver,23,24,21 gall bladder25 and colon26–29 cancer cell lines, however so far the main application is for hepatoma.30,31 Numerous research groups have reported various structural modifications of norcantharidin, ones in which protein phosphatase inhibition is maintained and others in which this activity is removed, but anti-proliferative activity is maintained.2–4,29,31–43 As is routine in our laboratory we conducted both protein phosphatase 1 and 2A inhibition studies, and in keeping with our earlier reports relating to similar cantharimides, all analogues herein were devoid of any protein phosphatase inhibitory properties.

    • Synthesis and biological activity of Δ-5,6-norcantharimides: importance of the 5,6-bridge

      2010, European Journal of Medicinal Chemistry
      Citation Excerpt :

      However through a series of modified literature procedures we gained access to the desired analogues (see Supplementary Material) [27–37]. With access to anhydrides 3–6, we were also keen to explore the SAR along similar lines to our prior evaluations with cantharidin and norcantharidin [16–25]. We thus investigated the development of small focused libraries of imides generated by treatment of anhydride 3–6 with a small library of amines (Scheme 1: Library A, amines a–f; Library B, amines g–l; Library C, amines m–p).

    • Interaction of calcineurin with its activator, chlorogenic acid revealed by spectroscopic methods

      2009, Biochimie
      Citation Excerpt :

      A number of other natural compounds such as FR901459 [5], polyunsaturated lipids [6], and retinoic acid [7], have inhibitory activity against CN. The second category consists of synthetic inhibitors, mainly metal ion chelates such as PD144795 and endothal derivatives [8,9]. Inhibitors of the third category are endogenous cellular proteins and may act in vivo as regulators of CN's function; examples are the 79 kDa protein kinase A anchoring protein AKAP79 [10], calcineurin binding protein-cain/cain1 [11] and the calcineurin regulator-RCN/MCIP/CBP1 [12].

    View all citing articles on Scopus
    View full text